Antiva Biosciencesincis A Clinical Stage Biopharmaceutical Company Based In Redwood Citycaliforniafounded In 2012 By Drkarl Hostetlerthe Company Focuses On Developing Topical Therapeutics Aimed At Treating Human Papillomavirushpvrelated Infections And Pre Cancerous Lesionstheir Mission Is To Prevent Cervical Cancer And Other Diseases Associated With Hpv Antiva S Lead Programs Include A Topical Antiviral Therapy Designed To Target High Grade Cervical And Anal Intraepithelial Neoplasiathe Company Utilizes A Proprietary Chemistry Platform That Optimizes Pro Drug Compounds For Localized Treatmentminimizing Systemic Side Effectswith Over 200 Pro Drug Candidates In Developmentantiva Aims To Provide A Non Surgical Solution That Can Replace Invasive Proceduresmaking Treatment More Accessibleespecially In Areas With Limited Surgical Optionsthe Company Actively Supports Global Health Initiativesincluding The Whoae S Cervical Cancer Elimination Initiativeby Offering Early Intervention Therapies For Patients
